4//SEC Filing
Kowalsky Matthew Paul 4
Accession 0001062993-24-009175
CIK 0001177648other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 4:27 PM ET
Size
5.6 KB
Accession
0001062993-24-009175
Insider Transaction Report
Form 4
Kowalsky Matthew Paul
Chief Legal Officer
Transactions
- Award
Stock Option (right to buy)
2024-04-29+150,000→ 150,000 totalExercise: $13.25Exp: 2034-04-29→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of such option will become exercisable on April 29, 2025 (the "Anniversary Date"), with the remainder to become exercisable quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over three years from the Anniversary Date (in each case subject to the optionholder's continued employment).
Issuer
ENANTA PHARMACEUTICALS INC
CIK 0001177648
Entity typeother
Related Parties
1- filerCIK 0001705824
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 4:27 PM ET
- Size
- 5.6 KB